Cargando…

microRNA‐221 rescues the loss of dopaminergic neurons in a mouse model of Parkinson's disease

BACKGROUND: Parkinson's disease (PD) is one of the most common systemic neurodegenerative diseases and is related to the loss of dopaminergic neurons in the substantia nigra. Several studies verified that microRNA (miRNAs) targeting the Bim/Bax/caspase‐3 signaling axis is involved in the apopto...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yao, Yufang, Zhao, Zhiyue, Zhang, Fubo, Miao, Na, Wang, Nan, Xu, Xin, Yang, Chaoping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10013949/ https://www.ncbi.nlm.nih.gov/pubmed/36795044 http://dx.doi.org/10.1002/brb3.2921

Ejemplares similares

Functional Rescue of Dopaminergic Neuron Loss in Parkinson's Disease Mice After Transplantation of Hematopoietic Stem and Progenitor Cells
por: Altarche-Xifro, Wassim, et al.
Publicado: (2016)

MicroRNA-212-5p Prevents Dopaminergic Neuron Death by Inhibiting SIRT2 in MPTP-Induced Mouse Model of Parkinson’s Disease
por: Sun, Sifan, et al.
Publicado: (2018)

Parkinson's disease and dopaminergic neurons
Publicado: (2012)

Acetylation of NDUFV1 induced by a newly synthesized HDAC6 inhibitor HGC rescues dopaminergic neuron loss in Parkinson models
por: Li, Bing, et al.
Publicado: (2021)

Loss of Drosha underlies dopaminergic neuron toxicity in models of Parkinson’s disease
por: Wang, Ronglin, et al.
Publicado: (2018)

Role of MicroRNAs-221/222 in Digestive Systems
por: Matsuzaki, Juntaro, et al.
Publicado: (2015)

Plasma Levels of microRNA-221 (miR-221) are Increased in Patients with Acute Pulmonary Embolism
por: Liu, Tingwei, et al.
Publicado: (2018)

Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate
por: Mamelak, Mortimer
Publicado: (2018)

Molecular Imaging of Striatal Dopaminergic Neuronal Loss and the Neurovascular Unit in Parkinson Disease
por: Ivanidze, Jana, et al.
Publicado: (2020)

Azilsartan ameliorates apoptosis of dopaminergic neurons and rescues characteristic parkinsonian behaviors in a rat model of Parkinson’s disease
por: Gao, Qing, et al.
Publicado: (2017)

MMP-3 Contributes to Nigrostriatal Dopaminergic Neuronal Loss, BBB Damage, and Neuroinflammation in an MPTP Mouse Model of Parkinson's Disease
por: Chung, Young Cheul, et al.
Publicado: (2013)

Inhibition of rho kinase enhances survival of dopaminergic neurons and attenuates axonal loss in a mouse model of Parkinson’s disease
por: Tönges, Lars, et al.
Publicado: (2012)

Long-term hyperglycemia aggravates α-synuclein aggregation and dopaminergic neuronal loss in a Parkinson’s disease mouse model
por: Lv, Yi-Qing, et al.
Publicado: (2022)

CLR01 protects dopaminergic neurons in vitro and in mouse models of Parkinson’s disease
por: Bengoa-Vergniory, Nora, et al.
Publicado: (2020)

HOTAIR drives autophagy in midbrain dopaminergic neurons in the substantia nigra compacta in a mouse model of Parkinson’s disease by elevating NPTX2 via miR-221-3p binding
por: Lang, Yue, et al.
Publicado: (2020)

Heptachlor induced nigral dopaminergic neuronal loss and Parkinsonism-like movement deficits in mice
por: Hong, Seokheon, et al.
Publicado: (2014)

Galangin Reduces the Loss of Dopaminergic Neurons in an LPS-Evoked Model of Parkinson’s Disease in Rats
por: Chen, Guangxin, et al.
Publicado: (2017)

Adjusting vascular permeability, leukocyte infiltration, and microglial cell activation to rescue dopaminergic neurons in rodent models of Parkinson’s disease
por: Cai, Hua-Ying, et al.
Publicado: (2021)

Neuromelanin Imaging and Dopaminergic Loss in Parkinson's Disease
por: Isaias, Ioannis U., et al.
Publicado: (2016)

Striatal Dopaminergic Loss and Dysphagia in Parkinson Disease
por: Kim, Ji Hwan, et al.
Publicado: (2023)

Vulnerability of Mesostriatal Dopaminergic Neurons in Parkinson's Disease
por: González-Hernández, Tomás, et al.
Publicado: (2010)

Curcumin inhibition of JNKs prevents dopaminergic neuronal loss in a mouse model of Parkinson’s disease through suppressing mitochondria dysfunction
por: Pan, Jing, et al.
Publicado: (2012)

NXP031 prevents dopaminergic neuronal loss and oxidative damage in the AAV-WT-α-synuclein mouse model of Parkinson’s disease
por: Song, Min Kyung, et al.
Publicado: (2022)

Overexpression of primary microRNA 221/222 in acute myeloid leukemia
por: Rommer, Anna, et al.
Publicado: (2013)

High expression of microRNA 221 is a poor predictor for glioma
por: Song, Yanlin, et al.
Publicado: (2020)

Progranulin Gene Delivery Protects Dopaminergic Neurons in a Mouse Model of Parkinson’s Disease
por: Van Kampen, Jackalina M., et al.
Publicado: (2014)

MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN
por: Chun-zhi, Zhang, et al.
Publicado: (2010)

Inhibiting the oncogenic mir-221 by microRNA sponge: toward microRNA-based therapeutics for hepatocellular carcinoma
por: Moshiri, Farzaneh, et al.
Publicado: (2014)

Treadmill exercise alleviates nigrostriatal dopaminergic loss of neurons and fibers in rotenone-induced Parkinson rats
por: Shin, Mal-Soon, et al.
Publicado: (2017)

Cav2.3 channels contribute to dopaminergic neuron loss in a model of Parkinson’s disease
por: Benkert, Julia, et al.
Publicado: (2019)

Cdk5 Inhibitory Peptide Prevents Loss of Dopaminergic Neurons and Alleviates Behavioral Changes in an MPTP Induced Parkinson’s Disease Mouse Model
por: He, Rongni, et al.
Publicado: (2018)

Up-regulation of microRNA-375 ameliorates the damage of dopaminergic neurons, reduces oxidative stress and inflammation in Parkinson’s disease by inhibiting SP1
por: Cai, Li-Jun, et al.
Publicado: (2020)

Roles of FGF20 in dopaminergic neurons and Parkinson's disease
por: Itoh, Nobuyuki, et al.
Publicado: (2013)

Inhibition of the mitochondrial calcium uniporter rescues dopaminergic neurons in pink1 (−/−) zebrafish
por: Soman, Smijin, et al.
Publicado: (2016)

Selenoprotein T Exerts an Essential Oxidoreductase Activity That Protects Dopaminergic Neurons in Mouse Models of Parkinson's Disease
por: Boukhzar, Loubna, et al.
Publicado: (2016)

Ketamine Does Not Exert Protective Properties on Dopaminergic Neurons in the Lactacystin Mouse Model of Parkinson’s Disease
por: Deneyer, Lauren, et al.
Publicado: (2018)

BMP5/7 protect dopaminergic neurons in an α-synuclein mouse model of Parkinson’s disease
por: Vitic, Zagorka, et al.
Publicado: (2020)

Knockout or inhibition of USP30 protects dopaminergic neurons in a Parkinson’s disease mouse model
por: Fang, Tracy-Shi Zhang, et al.
Publicado: (2023)

MicroRNA-221 silencing attenuates the degenerated phenotype of intervertebral disc cells
por: Penolazzi, Letizia, et al.
Publicado: (2018)

MicroRNA-221 promotes tumor progression by targeting HHIP in human glioblastoma
por: Chang, Liang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g8kspdobmuf25051hel8l0sdq0